Literature DB >> 21684749

Understanding the role of gut microbiome-host metabolic signal disruption in health and disease.

Elaine Holmes1, Jia V Li, Thanos Athanasiou, Hutan Ashrafian, Jeremy K Nicholson.   

Abstract

There is growing awareness of the importance of the gut microbiome in health and disease, and recognition that the microbe to host metabolic signalling is crucial to understanding the mechanistic basis of their interaction. This opens new avenues of research for advancing knowledge on the aetiopathologic consequences of dysbiosis with potential for identifying novel microbially-related drug targets. Advances in both sequencing technologies and metabolic profiling platforms, coupled with mathematical integration approaches, herald a new era in characterizing the role of the microbiome in metabolic signalling within the host and have far reaching implications in promoting health in both the developed and developing world.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21684749     DOI: 10.1016/j.tim.2011.05.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  151 in total

1.  Obesity and the gut microbiome: Striving for causality.

Authors:  Isaac T W Harley; Christopher L Karp
Journal:  Mol Metab       Date:  2012-08-03       Impact factor: 7.422

Review 2.  Clinical metabolomics: the next stage of clinical biochemistry.

Authors:  Angelo D'Alessandro; Bruno Giardina; Federica Gevi; Anna Maria Timperio; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 3.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

4.  The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice.

Authors:  Jason L O'Loughlin; Derrick R Samuelson; Andrea G Braundmeier-Fleming; Bryan A White; Gary J Haldorson; Jennifer B Stone; Jeremy J Lessmann; Tyson P Eucker; Michael E Konkel
Journal:  Appl Environ Microbiol       Date:  2015-05-01       Impact factor: 4.792

Review 5.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

Review 6.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

Review 7.  Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.

Authors:  Samuel Philip Nobs; Timur Tuganbaev; Eran Elinav
Journal:  EMBO Rep       Date:  2019-03-15       Impact factor: 8.807

Review 8.  Metabolomics Signatures of Aging: Recent Advances.

Authors:  Sunil S Adav; Yulan Wang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

Review 9.  How nutrition and the maternal microbiota shape the neonatal immune system.

Authors:  Andrew J Macpherson; Mercedes Gomez de Agüero; Stephanie C Ganal-Vonarburg
Journal:  Nat Rev Immunol       Date:  2017-06-12       Impact factor: 53.106

10.  New perspectives regarding the antiviral effect of vitamin A on norovirus using modulation of gut microbiota.

Authors:  Heetae Lee; GwangPyo Ko
Journal:  Gut Microbes       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.